SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: VLAD who wrote (20094)3/25/1999 11:11:00 AM
From: Little Gorilla  Read Replies (2) | Respond to of 23519
 
Anyone know anything about the agreement Vivus has with its current marketing partners? What percentage goes to Vivus?



To: VLAD who wrote (20094)3/25/1999 2:23:00 PM
From: blankmind  Read Replies (1) | Respond to of 23519
 
VLAD, c'mon, you really think either outfit needs to merge to do any of this?

- I agree it would be a logical extension

- But then again, I thought yesterday's Alibra patent would have catapulted us to $10

- And the female drug announcement...

- I don't even want to talk about the cartwheels I was doing over the FDA approval of the new plant

- Anyway... Go vivus.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News